Evolving paradigms in the medical treatment of glaucoma

International Ophthalmology
John S CohenLinda J Greff

Abstract

In the last 5 years, numerous novel ocular hypotensive agents have been introduced for the control of intraocular pressure (IOP). Clinicians now have more options than ever in medical therapy for the treatment of glaucoma and ocular hypertension. When selecting an ocular hypotensive medication for their patients, clinicians should consider not only the IOP-lowering efficacy of an agent but also the ability of the drug to achieve target levels of IOP that are low enough to stop the progression of glaucomatous damage. Other considerations should include how well the drug controls diurnal IOP, the likelihood of serious adverse events, the versatility of the medication for use as an adjunctive agent, as well as other potential attributes (e.g., neuroprotection).

References

Apr 1, 1977·Archives of Ophthalmology·T J Zimmerman, H E Kaufman
Oct 1, 1979·American Journal of Ophthalmology·C D McMahonJ Hetherington
Jan 1, 1990·The British Journal of Ophthalmology·R VogelC J Bulpitt
Aug 15, 1986·American Journal of Ophthalmology·L S HarrisA F Bloom
Nov 15, 1986·American Journal of Ophthalmology·W L NelsonJ N Kuritsky
Aug 1, 1983·Archives of Internal Medicine·T M Velde, F E Kaiser
May 1, 1980·Ophthalmology·E M Van Buskirk
Aug 1, 1993·Australasian Radiology·R G Schamschula, M Y Soo
Jan 1, 1996·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·T TaniguchiY Kitazawa
Dec 1, 1996·Acta Ophthalmologica Scandinavica·A HarrisB Martin
Apr 1, 1997·Journal of Glaucoma·H D Jampel
Feb 1, 1997·Survey of Ophthalmology·T YamamotoK Masuda
Nov 21, 1997·Archives of Ophthalmology·L WaymanR Brubaker
Apr 29, 1998·Journal of the American Optometric Association·I B Gaddie, D W Bennett
Jul 31, 1998·American Journal of Ophthalmology·R D FechtnerR Warwar
May 20, 1999·American Journal of Ophthalmology·M WandT J Liesegang
Jul 23, 1999·Survey of Ophthalmology·N N OsborneM S Nash
Feb 15, 2000·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·D A LeeC Abrams
Apr 18, 2000·Ophthalmology·K SinghD Minckler
Apr 25, 2000·Drugs·P F Hoyng, L M van Beek
Apr 12, 2001·Ophthalmology·A R KentD Fellows
May 30, 2001·Survey of Ophthalmology·L A WheelerE WoldeMussie

❮ Previous
Next ❯

Citations

Dec 22, 2010·Indian Journal of Ophthalmology·Kuldev Singh, Anurag Shrivastava
Jan 26, 2017·The Cochrane Database of Systematic Reviews·Dayse F Sena, Kristina Lindsley
Jan 1, 2010·Expert Review of Clinical Pharmacology·Simon MantellMike Trevethick

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.